FDA gives CryoLife conditional approval for PerClot device

06/20/2013 | American City Business Journals

The FDA has granted CryoLife conditional investigational device exemption approval for its PerClot system. The company said the device, which consists of absorbable polysaccharide granules, is designed for use as an ancillary hemostatic tool when conventional methods to control bleeding during surgery are impractical or ineffective.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX